Publication | Closed Access

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Cannabis UseMolecular PharmacologyFunctional SelectivityAddictionDrug DiscoveryMedicineNeuropharmacologyAddiction MedicineOpioid/cannabinoid Interaction StudiesPharmacotherapyNeuroscienceDirect AntagonistsPharmacologyCannabinoid PharmacologyOpioid Use DisorderRimonabant ActHealth Sciences